Related Experiment Video

Updated: Jun 1, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

TRPM2 modulates insulin secretion in pancreatic β-cells

Kunitoshi Uchida1, Makoto Tominaga

  • 1Division of Cell Signaling, Okazaki Institute for Integrative Bioscience, National Institute of Physiological Sciences, National Institutes of Natural Sciences, Okazaki, Aichi, Japan.

Islets
|June 4, 2011
PubMed

Insights

The TRPM2 channel in pancreatic beta-cells is crucial for insulin secretion, impacting glucose regulation. TRPM2 channel (transient receptor potential melastatin 2) dysfunction impairs glucose tolerance and insulin release.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Physiology

Background:

  • Insulin secretion by pancreatic beta-cells is vital for blood glucose homeostasis.
  • Glucose-stimulated insulin secretion (GSIS) primarily involves ATP-sensitive K+ channels and voltage-gated Ca2+ channels.
  • Transient Receptor Potential (TRP) channels are implicated in beta-cell function and insulin secretion.

Purpose of the Study:

  • To investigate the role of the TRPM2 channel in pancreatic beta-cells.
  • To elucidate the contribution of TRPM2 to glucose-stimulated insulin secretion and incretin hormone potentiation.
  • To assess the impact of TRPM2 deficiency on glucose tolerance and insulin secretion.

Main Methods:

  • Expression analysis of TRPM2 in pancreatic beta-cells.
  • Electrophysiological characterization of TRPM2 channel activity (activation by adenosine dinucleotides, H2O2, Ca2+).
  • Assessment of glucose tolerance and insulin secretion in TRPM2 knockout mice.

Main Results:

  • TRPM2 channels are expressed in pancreatic beta-cells and modulate insulin secretion.
  • TRPM2 knockout mice exhibit impaired glucose tolerance and reduced insulin secretion.
  • TRPM2 influences insulin secretion through both intracellular Ca2+ concentration control and Ca2+ influx-independent pathways.

Conclusions:

  • TRPM2 plays a significant role in regulating insulin secretion from pancreatic beta-cells.
  • TRPM2's involvement in insulin secretion suggests it as a potential therapeutic target for diabetes.
  • Further research is needed to fully elucidate the precise mechanisms of TRPM2-mediated insulin secretion.

More Related Videos

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...